CS199313B1 - Esters of thiophosphoric acid and process for preparing thereof - Google Patents

Esters of thiophosphoric acid and process for preparing thereof Download PDF

Info

Publication number
CS199313B1
CS199313B1 CS880478A CS880478A CS199313B1 CS 199313 B1 CS199313 B1 CS 199313B1 CS 880478 A CS880478 A CS 880478A CS 880478 A CS880478 A CS 880478A CS 199313 B1 CS199313 B1 CS 199313B1
Authority
CS
Czechoslovakia
Prior art keywords
oxo
yield
calculated
oxy
analysis
Prior art date
Application number
CS880478A
Other languages
Czech (cs)
Slovak (sk)
Inventor
Vaclav Konecny
Vojtech Kubala
Original Assignee
Vaclav Konecny
Vojtech Kubala
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vaclav Konecny, Vojtech Kubala filed Critical Vaclav Konecny
Priority to CS880478A priority Critical patent/CS199313B1/en
Publication of CS199313B1 publication Critical patent/CS199313B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

Predemetom vynálezu sú nové 2-/5-alkoxy, alkyltio, chlór-l-alkyl, cyklohexyl, fenyl-6-oxo-lH-pyridazín-4-oxy/l,2,3-dioxafosfolan/fosforinan/-2-tiony a sposob ich přípravy. Nové zlúčeniny majú ovioídne účinky.The subject of the invention is the novel 2- (5-alkoxy, alkylthio, chloro-1-alkyl, cyclohexyl, phenyl-6-oxo-1H-pyridazin-4-oxy) 1,2,3-dioxaphospholan (phosphinanane) -2-thiones and method of their preparation. The novel compounds have ovioid effects.

Z literatúry sú známe příbuzné pyridazín-4-yl estery organofosforovýoh kyselin vzorcaRelated pyridazin-4-yl esters of organophosphoric acids of the formula are known in the literature

Rc R c

- R v ktorom R? znamená alkyl, alkoxy, Ν,Ν-dialkylamido, R2 znamená alkoxy, alkyltio, N-alkylamido, Ν,Ν-dialkylamido, R^ znamená halogén, alkoxy, alkyltio, íft znamená alkyl, cykloalkyl, fenyl a benzyl, X znamená kyslík, síru (čsl. pat. 133 599 a 141 95D·- R in which R? R 2 is alkyl, alkoxy, Ν, Ν-dialkylamido, R 2 is alkoxy, alkylthio, N-alkylamido, Ν, Ν-dialkylamido, R 6 is halogen, alkoxy, alkylthio, t is alkyl, cycloalkyl, phenyl and benzyl, X is oxygen , sulfur (art. no. 133 599 and 141 95D ·

Teraz sa zistili nové zlúčeniny všeobecného vzorca INew compounds of the formula I have now been found

199 313199 313

199 313 ir199 313 ir

v ktorom R^ znamená skupiny -CHg-CHg-, -CH/CH2/-CH//CH3/-, -CHg-CHg-CH/CH^/-» -CHg-C/CH^/g -CHg-, R2 znamená vodík, chlór, alkoxy, alkyltio, vždy s 1 až 3 atómami C v alkylskupinách, R^ znamená alkyl s 1 až 3 atómami C, cyklohexyl, fenyl.wherein R 1 is -CH 2 -CH 2 -, -CH 2 -CH 2 -CH 3 -CH 3 -, -CH 2 -CH 2 -CH (CH 2) -, -CH 2 -C (CH 2) -, g -CH 3 -, R 2 is hydrogen, chloro, alkoxy, alkylthio, in each case having 1 to 3 C atoms in the alkyl groups, R 1 is alkyl having 1 to 3 C atoms, cyclohexyl, phenyl.

Súčasne sa zistil sposob přípravy zlúčenin vzorca I reakciou 2-chlór-l,3,2-dioxafosfolan-2-tionu, resp. 2-chlór-l,3,2-dioxafosforinan-2-tionu vzorca IIAt the same time, a process for the preparation of the compounds of the formula I by reaction of 2-chloro-1,3,2-dioxaphospholane-2-thion, respectively, was determined. 2-chloro-1,3,2-dioxaphosphorinan-2-thione of formula II

R1 R 1

PP

Cl (II) v ktorom R^ má už uvedený výhnam s alkalickou eoíou l,5-disubstituovaného-6-oxo-lH-pyri-Cl (II) in which R1 has the above-mentioned advantage with an alkali salt of 1,5-disubstituted-6-oxo-1H-pyrrole;

dazín-4-olu vzorca III dazin-4-ol of formula III (+) (+) (-) (-) M M 1 , ' íin) 1 ) 0 0 2 7 v ktorom R a RJ majú už uvedenýIn which R and R J have already been mentioned význam, M znamená draslík, alebo sodík v prostředí M is potassium or sodium in the environment

organického rozpúfifadla, ako je acetonitril, dioxán, dimetylformamid, dimetylsulfoxid, metyletylketón, octan stylový, octan butylový, tetrahydrofurén pri tepiote 40 až 100 °C.an organic solvent such as acetonitrile, dioxane, dimethylformamide, dimethylsulfoxide, methyl ethyl ketone, stylish acetate, butyl acetate, tetrahydrofuran at a temperature of 40 to 100 ° C.

Nasledujúce příklady objasňujú, ale neobmedzujú nové zlúčeniny podía vynálezu a aposob ioh přípravy.The following examples illustrate, but do not limit, the novel compounds of the invention and methods of preparation.

Příklad 1Example 1

2-/5-met oxy-l-metyl-6-oxo-lH-pyridazín-4-oxy/-l,3»2-d ioxafosofolan-2-tion KO,O55 molu draselnéj soli 5-metoxy-l-metyl-6-oxo-lH-pyridazín-4-ólu v 100 ml acetonitril· sa přidalo 0,05 molu 2-chlór-l,3,2-dioxafosfolan-2-tionu. Reakčná zmes sa mieěala 2 hodiny pri refluxe. Po ukončení a ochladnutí sa za miešania vyliala do 500 ml vody. Vylúčená tuhá látka sa oddělila filtráciou, přečistila kryštalizáciou z toluénu. Získalo sa 11,3 g bielej kryštalickej látky s t.t. 66-67 °C, čo odpovědí 85%-nému výtažku zloženia: Analýza: Pre CgH^N^PS Vyp.: lljl3 % p 11,52 % S 10,07 % N (m.h.: 278,2) Zist.: 11,28 % P 11,81 % S 10,06 % N2- (5-Methoxy-1-methyl-6-oxo-1H-pyridazine-4-oxy) -1,3,2-dioxioxaphosopholane-2-thion KO, O55 mole of 5-methoxy-1-methyl potassium salt 6-oxo-1H-pyridazin-4-ol in 100 mL of acetonitrile was added 0.05 mol of 2-chloro-1,3,2-dioxaphospholane-2-thione. The reaction mixture was stirred at reflux for 2 hours. After completion and cooling, it was poured into 500 ml of water with stirring. The precipitated solid was collected by filtration and purified by crystallization from toluene. Yield: 11.3 g of white crystalline solid, mp 66-67 ° C, corresponding to 85% yield calculated composition: Calculated for N? CGH HP lljl3 Calc .: 11.52% P% N% S 10.07 (MW: 278.2) Found: 11.28% P 11.81% S 10.06% N

Štruktúra pripravenej látky bola dokázaná ifi a UV spektrami .The structure of the prepared substance was proved by ifi and UV spectra.

188 313 ΐδ namerané v CHCl-j.188 313 ΐδ measured in CHCl-j.

^(0=0) ^ (0 = 0) : 1647 cm1 : 1647 cm 1 V (C-C) : V (C-C): 927 927 -1 om -1 om V(C=N) V (C = N) : 1617 om1 : 1617 om 1 V (OP) : V (OP): 882 882 cm1 cm 1 V(C-N) In (C-N) : 1381 om1 : 1381 om 1 Ϋ (OP) : OP (OP): 835 835 om1 om 1

V(C-0) : 1032 cm1 H (C-0): 1032 cm @ -1

UV namerané v CH^OHsUV measured in CH 2 OH 3

Ά- max : 213 nm, 284 nm. ,Max max: 213 nm, 284 nm. .

Podobným postuporn boli připravené následovně látky.Substances were prepared in a similar manner.

Příklad 2Example 2

2-(l-fenyl - 5-metoxy-6-oxo-lH-pyridazín-4-oxy/-l,3,2-doxafoslan-2-tion t.t. = 168-170 °C (výřažok: 59,1 %)2- (1-phenyl-5-methoxy-6-oxo-1H-pyridazine-4-oxy) -1,3,2-doxaphoslan-2-thione mp = 168-170 ° C (yield: 59.1%)

Analýza: vypočítané: 9,10 % PAnalysis: calculated: 9.10% P

9,20 % P zistené:9.20% P found:

0,42 % S 9,81 % S0.42% S 9.81% S

8,25 % N 8,10 % N l6 v CHCI.: 'Ý (C=0) : 1650 om1, V (C=N) : 1628 cm1 8.25% N 8.10% N .: CHCl L6 in the Y (C = 0) 1650 OM 1, V (C = N) 1628 cm 1

UV v CH-jOH:UV in CH-jOH:

max : 213 nm, 288 nmmax: 213 nm, 288 nm

Příklad 3Example 3

2-/5-metoxy-l-metyl-6-oxo-lH-pyridazín-4-oxy/-4,5-dimetyl-l,3,2-dioxafosfolan-2-t ion n20 = 1,5421 (výíažok: 68,3)2- (5-methoxy-1-methyl-6-oxo-1H-pyridazine-4-oxy) -4,5-dimethyl-1,3,2-dioxaphospholan-2-one ion 20 = 1.5421 (yield) : 68.3)

DD

Analýza: vypočítané: 10,11 % P 10,77 % S 9,14 < N zistené: 10,23 % P 10,69 % S 9,44 % NAnalysis: calculated: 10.11% P 10.77% S 9.14 <N found: 10.23% P 10.69% S 9.44% N

Ιδ v CHC13: S1 (0=0) i 1645 om1, V(C=N) : 1 620 cm1 Ιδ in CHCl 3 : S 1 (0 = 0) i 1645 µm 1 , V (C = N): 1 620 cm 1

UV v CH30H:UV in CH 3 0H:

max : 213 nm, 286 nmmax: 213 nm, 286 nm

Přiklad 4 ‘Example 4 ‘

2-/l-fenyl-5-met oxy-6-oxo-lH-pyridazín-4-oxy/-4,5-dimetyl-l,3,2-dioxafoafolan-2-t ion2- (1-Phenyl-5-methoxy-6-oxo-1H-pyridazin-4-oxy) -4,5-dimethyl-1,3,2-dioxafoafolan-2-one

t.t. = 91 - mp = 91 - 92 °C (vyfažok; 71,2 %}  92 ° C (yield; 71.2%) Analýza: analysis: vypočítané: calculated: 8,41 % P 8.41% P 8,70 % S 8.70% N 7,61 7.61 % N % N zistené: found: 8,60 % P 8.60% P 8,71 % 3 8.71% 3 8,01 8.01 % N % N Ιδ v CHC13 Ιδ in CHC1 3 : V (C=0) : C (C = 0) : 1657 cm1,': 1657 cm 1 , ' V (C=N) V (C = N) : 1628 : 1628 om1 om 1 UV v CH3OHUV in CH 3 OH s max with max : 214 nm, : 214 nm, 296 nm 296 nm

Příklad 5Example 5

2-/l-fenyl-5-chlór-6-oxo-lH-pyridazín-4-oxy/-4,5-dimetyl-l,3,2-dioxafosfolan-2-tion2- / l-phenyl-5-chloro-6-oxo-pyridazin-4-yloxy / -4,5-dimethyl-3,2-dioxaphospholane-2-thione

t.t. = 110 - 111 °C mp M.p. = 110-111 ° C (výtažok: 69,1 %) (yield: 69.1%) Analýza:, vypočítané: zistené: Analysis: calculated: found: 8,31 % P 8,60 % S 8,41 % P 8,80% S 8.31% P 8.60% S 8.41% P 8.80% S 7,52 % N 7,68 % N N, 7.52 N, 7.68

199 313 lí v CHC13 : y (0=0) : 1670 cm1, Ϋ (C=N) s 1612 cm1 v CC14 : V (C=0) : 1684 cm1, V(C=N) j 1613 cm1 199 313 li in CHCl 3 : y (0 = 0): 1670 cm 1 , Ϋ (C = N) with 1612 cm 1 in CC 1 4 : V (C = 0): 1684 cm 1 , V (C = N) j 1613 cm 1

UV v CH30H : % aax : 212 vm, 302 nmUV in CH 3 OH:% aax : 212 in m, 302 nm

Příklad 6Example 6

2-/5-metoxy-l-metyl-6-oxo-lH-pyridazín-4-oxy/-6-metyl-l,3,2-dioxafosforinan-2-tion2- / 5-methoxy-l-methyl-6-oxo-pyridazin-4-yloxy / 6-methyl-l, 3,2-dioxaphosphorinane-2-thione

nD =1,5511 (vý£ažok: 89,6 %) n D = 1.5511 (yield: 89.6%) Analýza: vypočítané: Analysis: calculated: 10,11 % P 10.11% P 10,47 10.47 % S % WITH 9,14 % N N, 9.14 zistené: found: 9,90 % P 9.90% P 10,32 10.32 % S % WITH 9,o2 % N 9, N2% lí v CHC13: V (0=0)in CHC1 3 : V (0 = 0) : 1639 om : 1639 om \ y \ y (C=N) (C = N) : 1608 cm' : 1608 cm ' UV c CH,0H mDV. 3 ' maxUV c CH, 0H mDV . 3 'max : 213 nm, : 213 nm, 285 nm 285 nm

Příklad 7Example 7

2-/5-chlór-l-mwtyl-6-oxo-lH-pyridazín-4-oxy/-6-metyl-l,3,2-ddioxafosforinan-2-tion t.t. = 78-80 °C (výíažok: 84,7 %)2- (5-chloro-1-methyl-6-oxo-1H-pyridazine-4-oxy) -6-methyl-1,3,2-dioxaphosphorinan-2-thion m.p. = 78-80 ° C (yield: 84.7%)

Analýza: vypočítané: 9,97 % P 10,32 % S 9,02 % N zistené: 10,06 % P 10,21 % S 9,20 % NAnalysis: calculated: 9.97% P 10.32% S 9.02% N found: 10.06% P 10.21% S 9.20% N

V (C=N) : 1599 cm'H (C = N): 1599 cm -1

213 nm, 296 nm213 nm, 296 nm

10,06 % P iC v CHC13: V /0=0/ : 1644 cm1,10.06% P iC in CHCl 3 : V / 0 = 0 /: 1644 cm 1 ,

UV v CH30H:UV in CH 3 0H:

maxmax

Příklad 8Example 8

2-/l-fenyl-5-metoxy-6-oxo-lH-pyridazín-4-oxy/-6-metyl-l,3,2-dioxafosforinan-2-tion t.t. = 74 - 76 °C (výíažok: 88,0 %)2- (1-phenyl-5-methoxy-6-oxo-1H-pyridazine-4-oxy) -6-methyl-1,3,2-dioxaphosphorinan-2-thione m.p. = 74-76 ° C (yield: 88.0%)

Analýza: vypočítané: Analysis: calculated: 8,41 % P 8.41% P 8,70 % S 8.70% N 7,61 % N N, 7.61 zistené: 1 found: 1 8,43 % P 8.43% P 8,71 % S 8.71% N 7,60 % N 7.60% N iC v CHC13 : y (C=iC in CHCl 3 : γ (C = 0) : 1649 cm* 0): 1649 cm * -1. v- 1 . in (C=N) : 1620 cm1 (C = N): 1620 cm @ -1 OT v OHjOHt % OT v OHjOHt% : 212 nm, : 212 nm, 297 nm 297 nm

Příklad 9Example 9

2-/l-fenyl-5-chlór-6-oxo-lH-pyridazín-4-oxy/-6n>metyl-lf3,2-dioxafosforinan-2-tion t.t. = 136-138 °C (výtažok: 60,2 %)2- (1-phenyl-5-chloro-6-oxo-1H-pyridazine-4-oxy) -6-methyl-1,3,2-dioxaphosphorinan-2-thione m.p. = 136-138 ° C (yield: 60.2%)

Analýza: vypočítané: 8,31 % P 8,60 % S 7,52 % N zistené: 8,65 % P 8,81 % S 7,68 % NAnalysis: calculated: 8.31% P 8.60% S 7.52% N found: 8.65% P 8.81% S 7.68% N

Ifl v CHC13 : V (0=0) : 1761 cm1, V (C=N) : 1 613 cm1 v CC14 : (0=0) : 1685 cm1, V (c=N) : 1612 cm1 Ifl in CHCl 3 : V (0 = 0): 1761 cm 1 , V (C = N): 1613 cm 1 in CC 1 4 : (0 = 0): 1685 cm 1 , V (c = N): 1612 cm 1

UV v CH30H : %UV in CH 3 0H:%

212 nm, 309 nm max212 nm, 309 nm max

189 313189 313

Příklad 10Example 10

2-/l-i!ietyl-6-oxo-lH-pyridazín-4-oxy/-5,5-dimetyl-l, 3,2-dioxaf oaforinan-6-t ion t.t. = 114 - 115 °C (výfažok: 84,6 %)2- (1-diethyl-6-oxo-1H-pyridazine-4-oxy) -5,5-dimethyl-1,3,2-dioxaphthaforinan-6-one m.p. = 114 - 115 ° C (yield: 84.6%)

Analýza: vypočítané:Analysis: calculated:

zistené:found:

IČ v CHC13: V (0=0) :IR in CHC1 3: W (0 = 0):

UV v CH,0H: Λ _ :UV in CH, OH:

maxmax

10,67 % P 10,55 % P 1646 om10.67% P 10.55% P 1646 om

11,04 % S 9,65 % N% N, 11.04%

11,33 % S 9,51 % N11.33% N 9.51% N

Ϋ (C=N) : 1598 cm1 Ϋ (C = N): 1598 cm @ -1

211 nm, 292 nm211 nm, 292 nm

Příklad 11Example 11

2-/5-met oxy-l-metyl-6-oxo-lH-paridazín-4-oxy/-5,5-d imetyl-1,3,2-dioxafsforinan-2-tion2- (5-methoxy-1-methyl-6-oxo-1H-paridazine-4-oxy) -5,5-dimethyl-1,3,2-dioxaphosphorinan-2-thione

t.t. =98-99 °C (výťažok: 72, mp Mp = 98-99 ° C (yield: 72, 6 %) 6%) Analýza; vypočítané: 9,67 % P analysis; calculated: 9.67% P 10,01 10.01 % S % WITH 8,74 % N N, 8.74 zistené: 9,65 % P found: 9.65% P 10,19 10.19 % s % with 8,93 % N 8.93% N IČ v CHC13: V (C=0) : 1645 cm1 IR in CHC1 3: V (C = 0): 1645 cm 1 , v , in (C=N) : (C = N): ί 1618 cm1 ί 1618 cm 1 UV v CH30H: A max : 212 nm>UV in CH 3 OH: λ max : 212 nm > 285 nm 285 nm

Příklad 12Example 12

2-/5-chlór-l-metyl-6-oxo-lH-pyridazin-4-oxy/-5,5-dimetyl-l,3,2-dioxafosforinan-2-tion t.t. = 160 - 162 °C (výíažok: 83,0 %}2- (5-chloro-1-methyl-6-oxo-1H-pyridazin-4-oxy) -5,5-dimethyl-1,3,2-dioxaphosphorinan-2-thione m.p. = 160-162 ° C (yield: 83.0%)

Analýza: vypočítané: 9,54 % P zistené: 9,52 %PAnalysis: Calculated: 9.54% P Found: 9.52% P

IČ v CHCI * v CC1.IR in CHCl * in CC1.

V (C=0) Ϋ (C = : 1652 cm”1,V (C = 0) Ϋ (C = 1652 cm ” 1 )

0) : 1678 cm“1,0): 1678 cm 1 ,

98,87 % S 10,02 % S Ϋ (C=N) V (C=N)98.87% S 10.02% S C (C = N) V (C = N)

8,63 % NN, 8.63

8,86 % NN, 8.86

1602 cm 1602 cm'1602 cm 1602 cm '

Příklad 13Example 13

2-/5-etoxy-l-metyl-6-oxo-lH-pyridazín-4-oxy/-5,5-dimetyl-l,3,2-dioxafoeforinan-2-tion t.t. =95-96 °C (výťažok: 84,2 %)2- (5-ethoxy-1-methyl-6-oxo-1H-pyridazine-4-oxy) -5,5-dimethyl-1,3,2-dioxaphoreforinan-2-thion m.p. = 95-96 ° C (yield: 84.2%)

Analýza: vypočítané: 9,26 % P 9,58 % S zistené: 9,16 % P 9,65 % SAnalysis: calculated: 9.26% P 9.58% S found: 9.16% P 9.65% S

IČ v CHC13 : Ý (C=0) : 1645 cm1, V (C=N) UV v CH3OH: A. nax : 215 nm, 286 nmIR in CHC1 3: Y (C = 0): 1645 cm 1, v (C = N) in the UV-CH 3 OH: A nax 215 nm, 286 nm

8,38 % N 8,64 % NN 8.38% N 8.64%

1615 cm1 1615 cm 1

Příklad 14Example 14

2-/5-etyltio-l-metyl-6-oxo-lH-pyridazín-4-oxy/-5,5-dimetyl-l,3,2-dioxafosforinan-2-tion t.t. = 109 - UÓ °C (výťažok: 76,8 %)2- (5-ethylthio-1-methyl-6-oxo-1H-pyridazine-4-oxy) -5,5-dimethyl-1,3,2-dioxaphosphorinan-2-thione m.p. = 109 - UO ° C (yield: 76.8%)

Analýza: vypočítané: 8,84 % P 18,30 % S 7,99 % NAnalysis: Calculated: 8.84% P 18.30% S 7.99% N

18,53 % S 7,93 % N18.53% N 7.93% N

V (C=N) : 1580 cm : 212 nm, 322 nm zistené:H (C = N): 1580 cm: 212 nm, 322 nm found:

IČ v CHCI,: y (C=0)IR in CHCl3: y (C = 0)

8,76 % P : 1636 cm1,8.76% P: 1636 cm 1 ,

UV v ch3oh maxUV in 3 ohm max

189 313 Příklad 15 ’189 313 Example 15 ’

2-/5vpřopyltio-metyl-6-oxo-lH-pyridazín-4-oxy/-5,5-dimetyl-l,3,2-dioxafoafořinan-2-tion t.t. « 116 - 117 °C (výtažok: 90,1 %)2- (5-propylthiomethyl-6-oxo-1H-pyridazine-4-oxy) -5,5-dimethyl-1,3,2-dioxaphoafraninan-2-thion m.p. «116 - 117 ° C (yield: 90.1%)

7,90 %N 8,06 % NN 7.90% 8.06% N

Analýza: vypočítané: Analysis: calculated: 8,50 % P 8.50% P 18,09 % 18,09% ziatené: the garbage: 8r51 % P8 y 51% P 17,76 % 17,76% IČ v V CHC13 : VCHCl 3 : V (C=0) (C = 0) : 1636 cm 1,: 1636 cm 1 Ý Ý (C=N) : (C = N): v in CC14 : VCC1 4 : V (C=0) (C = 0) : 1645 cm“1,: 1645 cm 1 , Ϋ Ϋ (C=N) : (C = N): UV v UV v CH30H : ACH 3 OH: A max max : 212 nm, : 212 nm, 321 321 nm nm

Příklad 16Example 16

2-/l-etyl-5-chlóř-6-oxo-lH-pyridazín-4-oxy/-5,5“dimetyl-l,3,2-dioxafosforinan-2-tion2- / l-ethyl-5-chloro-6-oxo-pyridazin-4-oxy / 5,5 'dimethyl-3,2-dioxaphosphorinane-2-thione

t.t. mp = 130 = 130 - 131 °c - 131 ° C (výtažok: 86,3 %) (yield: 86.3%) Analýza: analysis: vypočítané: calculated: 9,14 % P 9.14% P 9,47 % 9.47% ziatené: the garbage: 8,98 % P 8.98% P 9,61 % 9,61% IČ v V chci3 I want 3 : Ϋ (0=0) : 0 (0 = 0) : 1652 cm1,1652 cm 1 V (C=N) V (C = N) v in CC14 CC1 4 : V (C=0) : C (C = 0) : 1667 om“1,: 1667 om ' 1 , V (C.=N) V (C. = N) UV v UV v CH30HCH 3 OH 5 max 5 max : 213 hm, 296 : 213 wt, 296 nm nm

8,27 % N 8,47 % N cm8.27% N 8.47% N cm

Příklad 17Example 17

2-/l-cyklohexyl-5-metoxy-6-oxo-lH-pyridazín-4-oxy/-5,5-dimetyl«l,3,2-dioxafosforinan-2-tion2- / l-cyclohexyl-5-methoxy-6-oxo-pyridazin-4-yloxy / -5,5-dimethyl «l, 3,2-dioxaphosphorinane-2-thione

t.t. = 110 - 112 °C (výtažok: 69,8 %)mp = 110-112 ° C (yield: 69.8%)

Analýza: vypočítané: 7,97 % 7 8,25 % S 7,21 % N ziatené: 7,88 % P 8,34 % S 7,31 % NAnalysis: Calculated: 7.97% 7 8.25% S 7.21% N Sealed: 7.88% P 8.34% S 7.31% N

IC v CHCI, : Ϋ (C=0) : 1639 cm1, ý(C=N) : 1620 cm“1 IC in CHCI, Ϋ (C = 0): 1639 cm 1 , ý (C = N): 1620 cm -1

UV v CH-jOH:UV in CH-jOH:

maxmax

215 nm, 287 nm215 nm, 287 nm

Příklad 18Example 18

2-/l-fenyl-5-metoxy-6-oxo-lH-pyridazín-4-oxy/5,5-dimetyl-l,3,2-dioxafoBforinan-2-tion2- / l-phenyl-5-methoxy-6-oxo-pyridazin-4-oxy / 5,5-dimethyl-3,2-dioxafoBforinan-2-thione

t.t. = 150 - 151 Cmp = 150-151 C

IČ v CHC13 : UV v CH-jOH :IR in CHC1 3: CH-UV in Joh:

ziatené (výřažok: 90,2 %)glazed (yield: 90.2%)

8,10 % P 8.10% P 8,39 % S 8.39% N 7,33 % N 7.33% N 8,24 % P 8.24% P 8,59 % S 8.59% N 7,24 % N N, 7.24 i) : 1653 (i): 1653 cm“1,' V (C=N)cm -1 , V (C = N) : 1625 cm1 : 1625 cm 1

: 216 nm, 296 nm max: 216 nm, 296 nm max

199 313199 313

PREDMET VYNÁLEZUOBJECT OF THE INVENTION

Claims (2)

PREDMET VYNÁLEZUOBJECT OF THE INVENTION 1, Estery kyseliny tiofosforeSnej všeobecného vzorca I v ktorom R1 znamená skupiny -CH2-CH2-, -CH(CH)3-CH/CH3)-, -CH2-CH2-CH/CH3)-, -CH2-C/CH3/2 -CH2“, R2 znamená vodík, chlór, alkoxy, alkyltio vždy s 1 až 3 atómami C v alkylskupinách, R^ znamená alkyl s 1 až 3 atómami C, cyklohexyl, fenyl.1, tiofosforeSnej acid esters of the formula I, wherein R 1 is -CH 2 -CH 2 -, -CH (CH) CH 3 / CH 3) -, -CH 2 CH 2 CH / CH 3) -, -CH2 C / CH3 / CH2 2 ', R 2 is hydrogen, chloro, alkoxy, alkylthio each having 1 to 3 carbon atoms in the alkyl groups, R is alkyl of 1 to 3 carbon atoms, cyclohexyl, phenyl. 2. Sposob pripravy zlúčenin vzorca I vyznačujúci sa tým, že sa nechá reagovač zlúSenina vzorca II (II)2. A process for the preparation of compounds of formula I, characterized in that a reagent of the compound of formula II (II) is left to react. Cl v ktorom R^ má už uvedený význam, s alkalickou soíou 1,5-disubatituovaného-6-oxo-lH-pyridazín-4-olu vzorca III (III) v ktorom R a RJ majú už uvedený význam, M znamená draslík, alebo sodík, v prostředí organického rozpúšťadla při teplote 40 až 100 °C.Cl wherein R is as defined above, with an alkali SALT-1,5-disubatituovaného-6-oxo-pyridazin-4-ol of formula III (III) wherein R and R @ J are as defined above, M is potassium, or sodium, in an organic solvent at a temperature of 40 to 100 ° C.
CS880478A 1978-12-22 1978-12-22 Esters of thiophosphoric acid and process for preparing thereof CS199313B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS880478A CS199313B1 (en) 1978-12-22 1978-12-22 Esters of thiophosphoric acid and process for preparing thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS880478A CS199313B1 (en) 1978-12-22 1978-12-22 Esters of thiophosphoric acid and process for preparing thereof

Publications (1)

Publication Number Publication Date
CS199313B1 true CS199313B1 (en) 1980-07-31

Family

ID=5439105

Family Applications (1)

Application Number Title Priority Date Filing Date
CS880478A CS199313B1 (en) 1978-12-22 1978-12-22 Esters of thiophosphoric acid and process for preparing thereof

Country Status (1)

Country Link
CS (1) CS199313B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8466096B2 (en) 2007-04-26 2013-06-18 Afton Chemical Corporation 1,3,2-dioxaphosphorinane, 2-sulfide derivatives for use as anti-wear additives in lubricant compositions

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8466096B2 (en) 2007-04-26 2013-06-18 Afton Chemical Corporation 1,3,2-dioxaphosphorinane, 2-sulfide derivatives for use as anti-wear additives in lubricant compositions

Similar Documents

Publication Publication Date Title
RU2378261C2 (en) Method of preparing salt compound (4,5-dihydroisoxazol-3-yl)thiocarboxamidine
EP0462639A1 (en) Preparation of 2-chloropyridine derivatives
DE69616240T2 (en) 1,2-dioxetane derivatives as active substances in chemiluminescence
PL108914B1 (en) Method of producing new derivatives of uracil
US5981786A (en) Process for producing (meth)acrylate derivatives
CS199313B1 (en) Esters of thiophosphoric acid and process for preparing thereof
US4195021A (en) 1,3-Disubstituted 2-azetidinone antibitotics
US4355172A (en) Process for 4-(D-3-amino-3-carboxypropoxy)-phenylglyoxylic acid oxime derivatives
EP0620228A1 (en) Novel reactive thiophosphate derivatives of thia(dia)zole acetic acid and process for preparing the same
US4440682A (en) Stereospecific synthesis of isocephalosporins and 2-oxa isocephalosporins
SU955861A3 (en) Process for producing derivatives of streptovaricin
US4305891A (en) Method for preparing O-4-(hydroxyalkyl)-thiophenyl phosphates
RU2027704C1 (en) Method of synthesis of 6-fluoro-1,2-benzisothiazole, ortho-substituted phenacyl-derivative, and a method of its synthesis
US4230871A (en) Process for preparing 5,6-dihydro-2-methyl-1,4-oxathiin derivatives
US4175076A (en) Azetidinone mercury sulfides and process therefor
CA1184178A (en) Optically-active diamide derivatives
FI71562C (en) FOERFARANDE FOER FRAMSTAELLNING AV 6- - SUBSTITUERADE PENICILLANSYRADERIVAT OCH SAOSOM MELLANPRODUKTER ANVAENDBARA 6-PERFLUORALKYLSULFONYLOXIPENICILLANSYRADERIVAT.
US4216333A (en) Process for preparing N-tritylimidazole compounds
US4918188A (en) Oxadiazines
US4542215A (en) Method for preparing 8-acylthio-1,2,3,4,5,6-hexahydro-2,6-methano-3,6(e),11(a)-trimethyl-3-benzazocines
CS217685B1 (en) New o-/2-chlorethyl/-o-isobutyl-o-/1-methyl-5-metoxy-6-oxo 1h-pyridazin-4-yl/thiopheosphate and method of making the same
US4226767A (en) Intermediates for 3-aminoazetidin-2-ones
SU1017703A1 (en) Process for preparing 3-methyl-5-oxo-2,2-bis(1,1.3-trihydroperfluoro-propoxy)-4-cyane-4-ethoxy carbonyl-1,2-azaphosphol-1-ene
PL172005B1 (en) Aryl hydroxyimidazolinylpropionamides
KR810001979B1 (en) Process for preparing 2,5-dihydro-1,2-thiazino(5,6-b)indol-3-carboxamides-1,1-dioxides